that asthma itself can impair growth. It is now over a hundred years since Hyde Salter, 2 describing the appearance of the asthmatic patient, commented that, 'if the asthma has come on young, he is generally below the average height. Some asthmatics, however ... have nothing whatever the matter with their appearance, and would be taken for perfectly healthy people.' In 1940 Cohen et al extended Hyde Salter's observations on asthma to encompass the entire spectrum of allergic disorders in childhood and emphasised the importance of recording height, weight, and physical maturity in assessing the progress of allergic children.3
They reported a spectrum of adverse effects on growth, the height being unaffected in milder cases but, with increasing severity of the allergic disease, there was impaired growth and finally delayed sexual maturation. In a later paper Cohen and Abram compared the growth of 150 allergic children with that of 102 age matched non-allergic controls and confirmed the association of uncontrolled allergy with growth impairment and found that satisfactory control of the allergic disease was associated with improved energy intake as well as satisfactory growth. 4 Since then, although it has been widely accepted that asthma might impair growth, the published evidence has been scanty and often difficult to 16 As in the studies related to chronic systemic steroid treatment, these children were highly selected, with severe intractable asthma justifying uprooting them from their homes and, although their growth was clearly impaired, it was by no means as severely restricted as that of children who had had previous steroid treatment -of patients in whom intermittent steroid treatment had been given, 15% had heights more than 2 SD below the predicted mean and, when steroids had been given continuously, 33% had heights more than 2 SD below the mean (fig 1) .
Falliers et al also compared the heights of CARIH children with those of 103 children seen in routine consulting practice before the advent of steroid therapy; they too showed growth retardation, with 73% of the heights lying below the normal mean for age, and 30% more than 2 SD below the normal mean. It is clear from these observations that growth retardation can occur in asthmatic children who have never been treated with corticosteroids, and that growth may be affected even in children with relatively mild asthma. Given in high prevalence of asthma, and the large numbers of paediatricians and general practitioners who run asthma clinics, it might be imagined that the literature would be inundated with reports describing the growth and development of asthmatic children with varying degrees of affliction. Such, alas, is not the case and reports of this type are surprisingly few and far between.
Snyder et al compared the growth of 91 children with asthma with that of children with other allergies and of healthy controls.17 In 74% of the asthmatics, the height was less than the 50th centile, and in 27% it was less than the 10th centile. In contrast, the height distribution of children in the other two groups was much more symmetrically distributed around the 50th centile. However, they also observed that the growth impairment of the asthmatic children was associated with delay in bone maturation and, therefore, with a good prognosis for ultimate adult height.
Murray et al reported that, of children attending their clinic and who had never received corticosteroids, 37% had a height below the 25th centile, and 7% had a height below the 3rd centile18; in other words, the proportion of small children was about twice as great as in the normal population. They adduced evidence that the important factors related to growth retardation were (a) onset of asthma before the age of 3 years; (b) chronic hypoxaemia; and (c) poor appetite and low milk intake. There was no association between growth retardation and low birth weight, frequency of respiratory tract infections, or frequency of fevers.
In a subsequent paper from the same group, the authors confirmed, in a large series of 598 children, the association between allergic respiratory tract disease (both asthma and allergic rhinitis) and short stature, with twice the predicted number of children falling below the 3rd centile for height.19 They also confirmed the presence of delayed bone age, adding support to the view that growth retardation in asthma is a maturational phenomenon, and the long term prognosis is good. Their findings also supported the view that the growth retardation reflects the atopic state in general and is not specific to asthma.
They also found raised triiodothyronine concentrations in seven of 16 asthmatic children with growth retardation, apparently providing a metabolic explanation for at least some cases of growth impairment, although this feature has never been reported again and Sole et al found no evidence of triiodothyronine toxicosis in their patients.20
In contrast, Spock studied 200 children with bronchial asthma seen at the Duke University Medical Center during a 10 year period and found that the height distribution was entirely normal.21 He attributed his failure to confirm the results of Falliers et al to the fact that the Denver children represented 'an especially severely afflicted asthmatic population'.
Kuzemko reported that, in the absence of steroid treatment, the height of asthmatic children is normal, although many are relatively light for their height.22 He also pointed out that many children with asthma have delayed puberty, a view later supported by Balfour-Lynn who performed a detailed long term prospective study of 66 children with chronic perennial asthma attending the Hammersmith Hospital in London.23 He found that prepubertal growth was normal but in later childhood about half the children showed deceleration of growth associated with delayed puberty. This delayed maturation was not related to the severity of the asthma, nor to its treatment and, as so often occurs with the combination of short stature and delayed maturation, eventual adult height was well within the range predicted by parental height.
Normal adult height was also reported by It is tempting to speculate that asthmatic children, who commonly suffer from night time symptoms with consequent sleep disturbance, might have impaired nocturnal growth hormone secretion. However, at the 1993 meeting of the British Paediatric Association, Professor Brook and his colleagues from the Middlesex Hospital presented the results of an analysis of the 24 hour growth hormone secretion profiles of asthmatic children, including children who were receiving no steroid treatment, and showed no evidence of reduced growth hormone secretion. Moreover, the administration of growth hormone has no effect on the growth of asthmatic children,28 although this has yet to be evaluated in undergrown asthmatic children who have not had corticosteroid treatment. 
